Cite

HARVARD Citation

    Ramonda, R. et al. (2022). Effectiveness and safety of secukinumab in axial spondyloarthritis: a 24-month prospective, multicenter real-life study. Therapeutic advances in musculoskeletal disease. p. . [Online]. 
  
Back to record